Business Context and Reporting Period
This Form 8-K filing by AVROBIO, Inc. (not Tectonic Therapeutic, Inc.) reports on the results of the 2021 Annual Meeting of Stockholders held on June 10, 2021. The company is incorporated in Delaware and trades on the Nasdaq Global Select Market under the symbol AVRO.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders approved two key proposals at the meeting:
- Election of Directors: Three Class III director nominees were elected to serve until the 2024 annual meeting.
- Bruce Booth, D.Phil.: 20,796,891 votes for; 9,809,137 votes withheld.
- Phillip Donenberg: 23,034,280 votes for; 7,571,748 votes withheld.
- Geoff MacKay: 23,680,999 votes for; 6,925,029 votes withheld.
- Ratification of Auditors: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
- Votes For: 35,480,674
- Votes Against: 11,851
- Abstentions: 36,831
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the company name discrepancy: The input metadata listed "Tectonic Therapeutic, Inc.," but the filing is for "AVROBIO, Inc."
- Confirm the tenure of the newly elected directors (Class III) extends through the 2024 annual meeting.
- Review the significant number of votes withheld for director nominee Bruce Booth compared to the other nominees.
- Check subsequent filings for the financial results of the fiscal year ending December 31, 2021, as this 8-K contains no financial data.